Medicare turns 55, and now’s the time to look at Part D – did it work?
On July 30, 1965, President Lyndon B. Johnson signed into law legislation that established the Medicare and Medicaid programs. The [...]
New Data Released: Higher cost-sharing for brand medicines experienced by commercially insured patients
Health plans are increasingly using deductibles and coinsurance to shift more of the cost of care to chronically ill patients [...]
Payers probably won’t pass COVID savings onto members, despite pandemic-driven boon
Payers were prepared for skyrocketing medical costs due to COVID, but the opposite happened: people consumed less healthcare, on average. [...]
Not interested: Pharma execs refuse White House meeting over drug pricing executive orders
Trump's recent executive orders linking drug prices in Medicare to lower prices abroad caused a significant rift with the pharma [...]
High-Value Care Every Time: Recommendations From The National Quality Task Force
To address the high-cost, low-value healthcare dilemma in the United States, the National Quality Forum (NQF) launched the National Quality [...]
Cytel Scientists Call for a “Statistician-First Workflow” to Optimize Drug Development
Adaptive trial designs within oncology are described by Cytel scientists, and address data, statistical, and commercial and scientific value of [...]
Incorporating Value-based Care Into Oncology
Value-based care within insurance design utilizes evidence-based medicine to distinguish high-value and low-value diagnostics and treatments. The goals of value-based [...]
Viewpoint in JAMA: Integrating Personalized Medicine with Population Health Management: The Path Forward
In this viewpoint article published in the Journal of the American Medical Association, the authors posit that genome-wide DNA sequencing [...]
A Military-Civilian Perspective on Real-World Evidence to Support Regulatory Decision Making
This article summarizes how the US Military Health System (MHS) used real-world data (RWD) during the Iraq and Afghanistan Wars [...]
New Report: Provider Perceptions of Value-Based Care
Provider Perceptions of Value-Based Care aimed to understand provider views on value-based care and their partnership with private and public [...]
BresMed White Paper: 8 Common Challenges with Rare Disease Drug Value and How to Address Them
BresMed, and international HEOR consultancy, developed a white paper exploring eight key challenges that manufacturers face when demonstrating the value [...]
Dread Expressed by Public Health Experts on Hurried FDA Signoff on COVID-19 Vaccine
Eighty-nine sites are enrolling patients in the landmark Phase 3 trial for Moderna Therapeutics vaccine kicked off on Monday, July [...]
New Platform for Affordable Genomic Cancer Profiling Launched
A next-generation sequencing reference laboratory will use artificial intelligence (AI) to advance precision medicine to determine genomic signatures, first for [...]
What Do Trump’s Drug Pricing Orders Mean, Other than Confusion?
Consistent with the status quo chaos that surrounds the White House, the Trump Administration's four drug pricing executive orders unveiled [...]
Lilly Partners with Prime Therapeutics: How Next Generation Value-based Arrangements Put Patients First
Value-based arrangements (VBA) are increasingly used, although most medicines are paid based on volume of product purchased or cost per [...]
Going on Now! AcademyHealth 2020 is Virtual Yet Vital: Here’s Why
Kicking off today, AcademyHealth 2020 will provide vital insights over a 2-week period from July 28 – August 6 with [...]
Showdown: White House Cancels Pharma Meeting on International Pricing
On Tuesday, July 28, the White House abruptly canceled a meeting with drug company executives to discuss the most favored [...]
Applications Sought for AMCP Board; Deadline is September 2
AMCP is seeking board members for the position of president-elect, treasurer, and two directors. Qualified candidates will possess the following competencies: [...]
Tufts Analyzes Cost-Effectiveness Analysis for 1974-2018
Kim et. al. of Tufts Medical Center published an examination in the journal Pharmacoeconomics assessing CEA and Global Health CEA [...]
ISPOR Offering Course on Causal Inference in Observational, Pragmatic Trials
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is offering a 4-hour course on causal inference in observational data [...]
IFAPP, MAPS Course Offers Certificate in Medicine Development
An online course hosted by IFAPP Academy in partnership with the Medical Affairs Professional Society (MAPS) aims to give medical [...]
Rho Experts to Explore Decentralized Trials
Rho's Rob Woolson and Derek Lawrence will discuss in an upcoming webinar how the company is helping trial sponsors get [...]
Former FDA Chief Talks Value-Based Care, Medical Tech
In a new Patients Rising podcast, former FDA Chief Mark McClellan explores how the COVID-19 pandemic has revealed the benefits [...]
ISPOR Webinar on Leadership Skills Nears
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) "Pathways to ISPOR Leadership" webinar is right around the corner. Registration [...]
Aetna Launching 2 New Plan Benefit Designs
Aetna announced plans to launch two new plan benefit designs aimed at addressing growing concerns by employers about high-deductible plans, [...]